Cargando…

Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs

Detalles Bibliográficos
Autor principal:	Leicht, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178625/ https://www.ncbi.nlm.nih.gov/pubmed/25252714 http://dx.doi.org/10.1186/1471-2334-14-S6-S8

Ejemplares similares

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews
por: Fernandes, Ricardo M, et al.
Publicado: (2017)

Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan
por: Zule, William A., et al.
Publicado: (2015)

Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
por: Kåberg, Martin, et al.
Publicado: (2022)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia"
por: Werb, Daniel, et al.
Publicado: (2009)

Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs
por: Resiak, Danielle, et al.
Publicado: (2022)

Organic Collaborative Research Partnership Building: Researchers, Needle and Syringe Program Providers, and People Who Inject Drugs
por: Resiak, Danielle, et al.
Publicado: (2021)

Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
por: Lindqvist, K., et al.
Publicado: (2023)

Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden
por: Kågström, E., et al.
Publicado: (2023)

High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review
por: Des Jarlais, Don C, et al.
Publicado: (2013)

Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study
por: Yee, Win Lei, et al.
Publicado: (2022)

Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh
por: Pasa, M. Kamal, et al.
Publicado: (2016)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran
por: Noroozi, Mehdi, et al.
Publicado: (2015)

Laboratory Study on Injection Force Measurement on Syringe and Needle Combinations
por: Prasetyono, Theddeus Octavianus Hari, et al.
Publicado: (2019)

Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: An evaluation
por: Pizzey, Rachael, et al.
Publicado: (2008)

Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume
por: Binka, Mawuena, et al.
Publicado: (2015)

Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions
por: Meyerson, Beth E., et al.
Publicado: (2018)

Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
por: Chatterjee, Avik, et al.
Publicado: (2023)

The Biomechanics and Optimization of the Needle-Syringe System for Injecting Triamcinolone Acetonide into Keloids
por: Vo, Anthony, et al.
Publicado: (2016)

Correction: Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume
por: Binka, Mawuena, et al.
Publicado: (2015)

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe
por: Kautz, Achim, et al.
Publicado: (2014)

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia
por: Maticic, Mojca
Publicado: (2014)

The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England
por: Whitfield, Mark, et al.
Publicado: (2020)

The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs
por: Schatz, Eberhard, et al.
Publicado: (2016)

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs
por: Barocas, Joshua A., et al.
Publicado: (2016)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

Randomized clinical trial: Direct‐acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection
por: Beer, Lewis, et al.
Publicado: (2022)

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Understanding the Reasons for Sharing Syringes or Needles to Inject Drugs: Conventional Content Analysis
por: Faghir-Gangi, Monireh, et al.
Publicado: (2020)

Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey
por: Lausevic, Dragan, et al.
Publicado: (2015)

Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis
por: Cepeda, Javier A, et al.
Publicado: (2019)

Commentary: the value of PrEP for people who inject drugs
por: Coleman, Rosalind L, et al.
Publicado: (2016)

Increasing vaccine supply with low dead-volume syringes and needles
por: Le Daré, Brendan, et al.
Publicado: (2021)

An Easily Overlooked Contamination of Syringes in Newborn Screening by Tandem Mass Spectrometry
por: Wang, Yanyun, et al.
Publicado: (2021)

In randomization we trust? There are overlooked problems in experimenting with people in behavioral intervention trials()
por: McCambridge, Jim, et al.
Publicado: (2014)

Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked
por: Bell, David S. H., et al.
Publicado: (2021)

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
por: Eckhardt, Benjamin J, et al.
Publicado: (2018)

Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange
por: Iyengar, Siddharth, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j3b8cm35j96i2o0k1b2kt9su87